May 16, 2019 Mustang Bio and Nationwide Children’s Hospital Receive Orphan Drug Designation for MB-108 (Oncolytic Virus C134) for the Treatment of Malignant Glioma
May 10, 2019 Mustang Bio Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
May 8, 2019 Mustang Bio Announces City of Hope Opens First-of-Its-Kind Multiple Myeloma CAR T Cell Therapy Trial Targeting CS1 Protein
April 17, 2019 St. Jude Children’s Research Hospital publishes results of Lentiviral Gene Therapy for Treatment of Infants with X-linked Severe Combined Immunodeficiency in New England Journal of Medicine
April 1, 2019 Mustang Bio Announces $20 Million Venture Debt Financing Agreement with Horizon Technology Finance